What Are The Barriers to HCV Treatment?

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Related Videos
Related Content

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection Severity

May 25th 2023

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection Severity

May 25th 2023

Weekly Roundup: The 5 Most Impactful Infectious Disease Stories You Need to Know

June 2nd 2023

World Hepatitis Day: Where Do We Go From Here?

July 28th 2022

Antiviral in Development for COVID-19 and HCV Treatment

June 1st 2023

“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs

March 18th 2022

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

FDA Approves Paxlovid for COVID-19 in Adults, Continues Strategy to Minimize Infection Severity

May 25th 2023
© 2023 MJH Life Sciences

All rights reserved.